Overview Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072 Status: Completed Trial end date: 2019-01-24 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the Pharmacokinetic Interaction Between AD-2071 and AD-2072 in healthy male volunteers. Phase: Phase 1 Details Lead Sponsor: Addpharma Inc.